CSIMarket
 


Syros Pharmaceuticals Inc   (SYRS)
Other Ticker:  
 

Cumulative Syros Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period

SYRS's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

SYRS Quick Ratio for Trailing Twelve Months Period

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities Growth -14.65 % -2.32 % 28.59 % 40.92 % 0.82 %
Y / Y Cash & cash equivalent Growth 50.37 % 55.18 % 67.93 % -52.6 % -50.36 %
Quick Ratio for Trailing Twelve Months Period 5.31 4.74 4.19 3.69 4.87
Total Ranking # 518 # 700 # 771 # 1050 # 868
Seq. Current Liabilities Growth -23.48 % -19.9 % -1.29 % 41.08 % -12.43 %
Seq. Cash & cash equivalent Growth -18.04 % -17.25 % 183.34 % -21.75 % -15.42 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2023
On the trailing twelve months basis Syros Pharmaceuticals Inc Cash & cash equivalent average soared by 50.37% in I. Quarter year on year, while Current Liabilities faded to $ 24 millions, this led to increase in in Syros Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period to 5.31, Quick Ratio for Trailing Twelve Months Period remained below Syros Pharmaceuticals Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 166 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Syros Pharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about SYRS
Quick Ratio SYRS in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 167
Sector # 277
S&P 500 # 399


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
8.9 5.51 3.69
(Dec 31 2017)   (Jun 30 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Metacrine Inc   14.55 
Seres Therapeutics Inc   14.35 
Pliant Therapeutics Inc   14.22 
Disc Medicine Inc   14.21 
Context Therapeutics Inc   13.99 
Prothena Corporation Public Limited Company  13.94 
Cryoport inc   13.82 
Compass Pathways Plc  13.75 
Eledon Pharmaceuticals Inc   13.75 
Centessa Pharmaceuticals Plc  13.73 
Reneo Pharmaceuticals Inc   13.60 
Crinetics Pharmaceuticals Inc   13.53 
Lumos Pharma Inc   13.38 
Lianbio  13.35 
Xenetic Biosciences Inc   13.15 
Alx Oncology Holdings Inc  12.77 
Hcw Biologics Inc   12.73 
Kronos Bio Inc   12.62 
Relmada Therapeutics Inc   12.54 
Immutep Limited  12.47 
Annovis Bio inc   12.45 
Erasca Inc   12.40 
Akero Therapeutics Inc   12.31 
Cerevel Therapeutics Holdings Inc   12.27 
Akouos inc   12.13 
Fulcrum Therapeutics Inc   12.09 
Acasti Pharma Inc   11.83 
Cormedix Inc   11.71 
Tyme Technologies Inc.  11.64 
Rocket Pharmaceuticals Inc   11.56 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071